A study of 500 early cardiogenic shock patients found that nearly one-quarter experienced poor outcomes, including increased risk of care escalation, deterioration, and in-hospital mortality. The research underscores the need for timely diagnosis and treatment to improve survival rates among this vulnerable population.
A nationwide study found that ambulatory surgery centers (ASCs) are treating 15% more patients from socially vulnerable areas for cardiac interventions, despite lower adverse event rates. The study also showed that ASC patients had a higher rate of repeat PCI compared to hospital outpatient department patients.
The ERGO-CATH study reveals traditional lead aprons cause 43% discomfort among interventional cardiologists due to high-risk positions like cervical axial rotation. Researchers advocate for novel lead-less solutions, such as the Rampart device, to shield staff from radiation exposure and prevent orthopedic pain.
A retrospective study found stenting to be associated with improved long-term outcomes, including lower risk of cardiovascular death and cardiac arrest. The study suggests that stenting should be considered a safe and effective treatment option for patients undergoing chronic total occlusion percutaneous coronary intervention.
A recent study highlights the alarming rise in cardiovascular deaths for those with obesity, disproportionately impacting minorities and women. Contrary to common perception, patients with obesity and critical limb ischemia experience significantly improved survival rates compared to non-obese patients.
A large registry study found that single antiplatelet therapy is associated with lower six-month mortality and major bleeding risk compared to dual antiplatelet therapy after transcatheter aortic valve replacement. This new standard of care may provide better outcomes for high-risk patients with coronary artery disease.
The SCAI/SCCT expert opinion document presents a comprehensive framework for using CCTA to guide PCI. It outlines current evidence and future opportunities, providing practical guidance on image acquisition, interpretation, and procedural strategy. The document aims to bridge the gap between imaging and intervention, emphasizing educat...
New findings from multiple studies demonstrate the significant benefit of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on cardiovascular outcomes like heart failure, acute myocardial infarction, and peripheral artery disease. GLP-1RA use has been associated with a lower risk of all-cause mortality in patients with type 2 diabetes.
The Society for Cardiovascular Angiography & Interventions (SCAI) meeting will highlight advances in interventional cardiology, including novel treatments and techniques. The conference features over 500 faculty, 700 posters, and 86 oral abstracts, with a focus on improving patient care and outcomes.
The Society for Cardiovascular Angiography & Interventions (SCAI) has published a groundbreaking educational resource, the first comprehensive procedural guide to T-TEER. The eBook provides step-by-step guidance on patient selection criteria, imaging protocols, and best practices for achieving optimal patient outcomes.
The Society for Cardiovascular Angiography and Interventions (SCAI) has selected 10 outstanding early-career interventional cardiologists for the JSCAI Editorial Fellowship Program 2025-26. The fellows will gain editorial experience, develop their skills as peer reviewers, and contribute to the journal's growth. They will also particip...
This special issue explores AI's applications across various subspecialties, including coronary interventions, structural heart disease, and cardiovascular imaging. It highlights the importance of responsible AI integration and addressing bias in decision support systems.
A survey by SCAI highlights alarming trends in radiation exposure and orthopedic injuries for interventional cardiologists and staff. The study proposes concrete steps to mitigate these hazards, including the adoption of new shielding technologies and expanding formal radiation safety education.
The Society for Cardiovascular Angiography and Interventions (SCAI) strongly supported the creation of an American Board of Cardiovascular Medicine, but the ABMS denied its proposal. This decision is a setback for establishing cardiology as its own distinct medical specialty.
The Society for Cardiovascular Angiography and Interventions has published an expert consensus statement recommending two preferred alternative access techniques for transaortic valve replacement (TAVR), including transcarotid and transcaval access. The guidelines aim to improve outcomes for patients with inadequate femoral vascular ac...
A new study published in JSCAI reveals a lower risk of cardiovascular events for people with Type 1 diabetes, compared to those with Type 2 diabetes. The research highlights the importance of distinguishing between the two types of diabetes and developing targeted treatment strategies.
The article proposes clear career paths and standardized training pathways in interventional heart failure, aiming to enable specialists to drive innovation and improve outcomes. It highlights the need for a formalized approach to training and career development in this field.
Frank J. Hildner, MD, FSCAI, was a founding member and past president of SCAI, establishing the organization's journal and promoting innovation in interventional cardiology. His legacy continues through the Hildner Lecture and numerous awards recognizing his contributions to cardiovascular care.
The Society for Cardiovascular Angiography and Interventions (SCAI) has successfully completed the first-ever Interventional Cardiology Match, marking a significant milestone in the field. The inaugural match saw an impressive participation rate, with 164 programs committing 326 positions.
A meta-analysis of seven randomized trials found that transcatheter aortic valve replacement (TAVR) has comparable long-term safety and efficacy to surgical aortic valve replacement (SAVR). However, TAVR was associated with an increased likelihood of needing a pacemaker and moderate-to-severe paravalvular leaks.
The Society for Cardiovascular Angiography and Interventions (SCAI) recognized several award recipients for their exceptional contributions to the field of interventional cardiology, including Dr. Antonio Colombo and Jonathan M. Tobis for the F. Mason Sones Distinguished Service Award, and Frank F. Ing for the Helping Little Hearts Lif...
The Society for Cardiovascular Angiography & Interventions (SCAI) awarded the Master Interventionalists of SCAI (MSCAI) designation to outstanding interventional cardiologists who demonstrate excellence in invasive/interventional cardiology. The designation recognizes clinical care, innovation, publication, and teaching achievements.
Dr. James B. Hermiller, MD, MSCAI, assumes presidency of Society for Cardiovascular Angiography & Interventions (SCAI) for 2024-25. With extensive experience in interventional cardiology and leadership roles, he aims to drive excellence in patient care.
The Society for Cardiovascular Angiography & Interventions (SCAI) presents its '30 in Their 30's' award to thirty early-career interventional cardiologists, recognizing their outstanding leadership and commitment to improving patient care. The recipients are the future of the field and will continue as valuable contributors to SCAI.
The Society for Cardiovascular Angiography & Interventions has selected 12 new early-career interventional cardiologists to participate in the Emerging Leader Mentorship Program. The program aims to enhance their skills and prepare them for leadership positions in medicine.
A new program at SCAI's Scientific Sessions provides medical students with hands-on experience in interventional cardiology. The program aims to increase diversity in the field by introducing students to various cases and devices used in Interventional Cardiology.
SCAI has announced the selection of Mariem A. Sawan as the 2024-25 SCAI-WIN CHIP Fellowship recipient, providing her with $115,000 funding to pursue advanced training in complex and high-risk coronary intervention. This fellowship will enable her to develop skills and knowledge in interventional cardiology.
The DurAVR Transcatheter Heart Valve has shown favorable results in improving hemodynamic performance and blood flow characteristics for patients with severe symptomatic aortic stenosis. The device was successfully implanted in 100% of cases, with no moderate or severe paravalvular leaks observed.
New clinical results show endovascular therapy as an effective and safe alternative to bypass surgery for both women and men with PAD. However, women remain underrepresented in PAD trials and are less likely to undergo endovascular revascularization.
Real-PE analysis reveals women and Black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients. The study found higher bleeding rates among women and white people compared to Black people.
The SMART trial demonstrates clinical non-inferiority and valve performance superiority of self-expanding valves (SEV) versus balloon-expandable valves (BEV) in aortic stenosis patients. The study shows improved hemodynamic outcomes over time, particularly for women with small annuli.
New data from the TVT Registry and Medicare linkage show that PCI can be safely performed at any time in relation to TAVR for patients with stable coronary artery disease. The analysis found similar composite outcomes for all-cause mortality and stroke at three years of follow-up, regardless of timing.
A new catheter-directed mechanical thrombectomy system demonstrated significant improvement in right ventricle function and minimal major adverse events in patients with acute intermediate-risk pulmonary embolism. The AlphaVac System achieved excellent thrombus removal with a wonderful safety profile.
A novel dual-action thrombectomy device effectively treated acute pulmonary embolism, restoring heart dimensions and blood flow. The study, known as ENGULF, found no major adverse events or deaths at 30 days, with significant improvements in the RV/LV ratio
A nationwide observational analysis found that TAVR was associated with lower odds of stroke, acute kidney injury, and major bleeding, as well as shorter length of stay and lower total costs compared to SAVR. The study suggests that TAVR is a more feasible and safe option for high-risk patients with AS and CS.
A novel score system, LM V-RESOLVE, uses three simple baseline angiographic findings to rapidly identify lesions at risk of side branch occlusion during left main bifurcation percutaneous coronary intervention. The model has good diagnostic accuracy and could inform clinical decision-making for high-risk patients.
A new gene therapy treatment has shown promise in increasing blood vessel growth, improving exercise duration, and reducing symptoms in patients with advanced coronary artery disease. The EXACT trial demonstrated a safety and efficacy profile, with improvements seen in exercise capacity, blood flow, and angina frequency.
A recent study reveals that lower-income patients are at a greater risk of heart attacks, while women, Black, and Hispanic patients are less likely to receive life-saving procedures. The incidence of STEMI has decreased by nearly 50% since 2004, but these disparities persist.
The Society for Cardiovascular Angiography and Interventions (SCAI) has awarded 3rd Annual Early Career Research Grants to support junior investigators in interventional cardiology. The grants, funded by Edwards Lifesciences, Medtronic, and Shockwave Medical, aim to advance scientific knowledge and impact clinical practice.
The CALORI Cardiac Catheterization trial found that a liberal non-fasting strategy significantly improved patient well-being and satisfaction, with better scores for hunger, fatigue, and nausea. Post-procedural satisfaction was also higher in the non-fasting group.
Underrepresented groups face disparities in PAD diagnosis and treatment due to limited clinical trials. Studies show inadequate Hispanic representation and higher hospital stays for these patients, emphasizing the need for enhanced screenings and education.
A study found radial arterial access superior to femoral access for coronary interventions, with lower rates of in-hospital mortality and major vascular complications. The use of radial access increased by more than 40% since 2013, representing a significant shift in practice.
A new study demonstrated AI's ability to extract functional and hemodynamics data from routine angiograms, revealing insights beyond human visibility. The AI-ENCODE study showed improved diagnostic capabilities and potential for positive patient outcomes.
Experts recommend increasing the use of intravascular ultrasound (IVUS) in lower extremity revascularization procedures to optimize outcomes and reduce complications. The technique provides detailed information about vessel walls, plaque composition, and blood flow characteristics, enabling more accurate diagnosis and treatment planning.
A new study analyzes data from the US cohort of the FLASH registry and shows that mechanical thrombectomy can significantly improve outcomes for patients with high-risk PE. The procedure is associated with a significant reduction in acute mortality among these patients.
A new study found significant racial and socioeconomic inequities in access to mechanical circulatory support for US patients with cardiogenic shock. Black patients were more likely to experience reduced access to life-saving therapies like mLVAD and ECMO, highlighting systemic disparities.
A novel study by a Japanese multicenter registry reveals significant benefits of using intravascular ultrasound (IVUS) in coronary interventions. The analysis showed reduced mortality and need for coronary bypass surgery in patients who underwent IVUS-guided procedures, highlighting its value in improving treatment outcomes.
A large real-world analysis provides vital insights into the safety of novel therapies for pulmonary embolism. Ultrasound-assisted catheter-directed thrombolysis emerged as the preferred approach due to its lower risk of complications, particularly major bleeding. The study also highlights the importance of individual patient character...
A new study assesses the safety and efficacy of radial access for peripheral artery interventions, finding it associated with favorable safety profiles and comparable procedural success rates. Radial access was also found to reduce bleeding complications and improve patient comfort, making it a potential alternative to traditional femo...
The SAFE-MCS study evaluates the safety of complex high-risk PCI using the Impella Heart Pump in conjunction with the Saranas Early Bird Bleed Monitoring System. The primary clinical endpoint is the incidence of access site-related Bleeding Academic Research Consortium (BARC) type III or V bleeding.